Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;69(12):1762-1772.
doi: 10.1111/jphp.12812. Epub 2017 Sep 5.

Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies

Affiliations

Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies

Lei Cao et al. J Pharm Pharmacol. 2017 Dec.

Abstract

Objectives: Excessive exposure to acetaminophen (APAP, paracetamol) can cause liver injury through formation of a reactive metabolite that depletes hepatic glutathione and causes hepatocellular oxidative stress and damage. Generation of this metabolite is mediated by Cytochrome-P450 (CYP) isoforms, mainly CYP2E1. A number of naturally occurring flavonoids can mitigate APAP-induced hepatotoxicity in experimental animal models. Our objective was to determine the mechanism of these protective effects and to evaluate possible human applicability.

Methods: Two flavonoids, luteolin and quercetin, were evaluated as potential inhibitors of eight human CYP isoforms, of six UDP-glucuronosyltransferase (UGT) isoforms and of APAP glucuronidation and sulfation. The experimental model was based on in-vitro metabolism by human liver microsomes, using isoform-specific substrates.

Key findings: Luteolin and quercetin inhibited human CYP isoforms to varying degrees, with greatest potency towards CYP1A2 and CYP2C8. However, 50% inhibitory concentrations (IC50 values) were generally in the micromolar range. UGT isoforms were minimally inhibited. Both luteolin and quercetin inhibited APAP sulfation but not glucuronidation.

Conclusions: Inhibition of human CYP activity by luteolin and quercetin occurred with IC50 values exceeding customary in-vivo human exposure with tolerable supplemental doses of these compounds. The findings indicate that luteolin and quercetin are not likely to be of clinical value for preventing or treating APAP-induced hepatotoxicity.

Keywords: CYPs; UDP-glucuronosyltransferase; acetaminophen; drug interactions; flavonoids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
In vitro inhibitory effects of luteolin on (a) CYP1A2, (b) CYP3A, (c) CYP2B6, (d) CYP2C8, (e) CYP2C9, (f) CYP2C19, (g) CYP2D6 and (h) CYP2E1. Data points represent the means ± standard errors (SEM) of each concentration that was tested in duplicate. The dashed and solid lines represent the incubations without and with preincubation. IC50 values were determined by nonlinear regression and summarized in Table 1.
Figure 2
Figure 2
In vitro inhibitory effects of quercetin on (a) CYP1A2, (b) CYP3A, (c) CYP2B6, (d) CYP2C8, (e) CYP2C9, (f) CYP2C19, (g) CYP2D6 and (h) CYP2E1. Data points represent the means ± standard errors (SEM) of each concentration that was tested in duplicate. The dashed and solid lines represent the incubations without and with preincubation. IC50 values were determined by nonlinear regression and summarized in Table 1.
Figure 3
Figure 3
In vitro inhibitory effects of luteolin and quercetin on (a and b) UGT1A1 or (c and d) UGT1A4. Data points represent the means ± standard errors (SEM) of each concentration that was tested in duplicate. The dashed and solid lines represent the incubations without and with preincubation. IC50 values were determined by nonlinear regression and summarized in Table 1. UGT, UDP-glucuronosyltransferase.
Figure 4
Figure 4
In vitro inhibitory effects of (a) luteolin, (b) quercetin and (c) probenecid on APAP glucuronidation with the pooled HLMs. The concentrations of probenecid are 0, 0.1, 0.25, 0.5, 1, 2.5 and 5 mm. Data points represent the means ± standard errors (SEM) of each drug concentration that was tested in duplicate. The dashed and solid lines represent the incubations without and with preincubation. IC50 values were determined by nonlinear regression and summarized in Table 1. HLM, human liver microsome.
Figure 5
Figure 5
In vitro inhibitory effects of (a) luteolin and (b) quercetin on acetaminophen sulfation. Data points represent the means ± standard errors (SEM) of each drug concentration that was tested in duplicate. IC50 values were determined by nonlinear regression and summarized in Table 1.
Figure 6
Figure 6
In vitro inhibition of CYP2E1 by (a) methanol and by (b) DMSO; and inhibition of CYP2C9 by (c) DMSO. Data points represent the means ± standard errors (SEM) of each solvent concentration that was tested in duplicate. IC50 values were determined by nonlinear regression and summarized in Table 1. DMSO, dimethyl sulfoxide.

References

    1. Larson AM et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364–1372. - PubMed
    1. Miner DJ, Kissinger PT. Evidence for the involvement of N-acetyl-p- quinoneimine in acetaminophen metabolism. Biochem Pharmacol 1979; 28: 3285–3290. - PubMed
    1. Laine JE et al. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica 2009; 39: 11–21. - PubMed
    1. Thummel KE et al. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 1993; 45: 1563–1569. - PubMed
    1. Manyike PT et al. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 2000; 67: 275–282. - PubMed

MeSH terms